Daridorexant for Alzheimer Disease Prevention

NCT07213349 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease (AD)

Interventions

DRUG: Daridorexant 50 mg
DRUG: Placebo

Sponsor

Douglas Mental Health University Institute

Collaborators

[object Object]